CPHI Milan, one of the world’s premier pharmaceutical raw material events, kicked off successfully. As a fully integrated manufacturer specializing in cephalosporin APIs, Titan Pharmaceutical （Titan Pharmaceutical Co., Ltd (Guangdong)） brought our professional team to this exhibition for intensive, in-depth exchanges with partners across the globe. Titan’s onsite delegation consisted of regulatory and international sales teams, fully demonstrating the company’s professional expertise and long-term commitment to the global marketplace.

Reuniting with Long-Term Partners to Build on Solid Cooperation

Titan Pharmaceutical’s booth saw continuous visitor traffic throughout the exhibition. Long-standing clients from Europe, the Americas, Southeast Asia, South Asia and the Middle East came to meet the Titan team face to face. The trust and rapport built over years of collaboration made every discussion warm and sincere.

These cross-border meetings transcend simple business transactions. At the booth, Titan Pharmaceutical’s team exchanged the latest market updates and industry insights with loyal partners, jointly analyzing regional demand shifts and regulatory trends. Drawing on extensive regulatory experience, the team offered professional advice and practical solutions for challenges clients encountered in registration and market access in various countries, supporting them to expand local market share and achieve mutual growth.

In-depth Discussions to Drive Project Cooperation Forward

CPHI Milan serves not only as a reunion for long-term partners but also as a platform to advance tangible business projects. During multiple high-level meetings, the Titan team reviewed ongoing cooperation projects in detail. For some clients, joint efforts yielded milestone breakthroughs to move projects to subsequent phases. Other partners openly shared bottlenecks in their current projects. The Titan team analyzed root causes item by item on site and proposed tailored solutions covering production, registration, quality control and logistics, reaching preliminary alignment on future timelines.

This partnership philosophy — beyond order-taking, focusing on problem-solving — lies at the heart of Titan Pharmaceutical’s reputation and trust earned from global customers over the years.

New Opportunities Emerge for Expanding Global Footprint

The exhibition also unlocked new potential cooperation opportunities for Titan Pharmaceutical. Prospective customers from diverse markets showed strong interest after learning about Titan Pharmaceutical’s product portfolio and certification credentials. The team discussed detailed requirements with these prospects and exchanged contact information, laying a solid foundation for follow-up market development and project communication.

Two Decades of Dedication: Strength Builds Trust

Titan Pharmaceutical has focused on the R&D and manufacturing of cephalosporin APIs for more than 20 years, establishing a full industrial chain covering API research, production, registration and export. Its product portfolio includes core varieties such as Cefuroxime Axetil Amorphous, Cefuroxime Sodium Sterile and Cefuroxime Axetil DC Grade, supplying global customers with consistent quality and dependable delivery schedules.

International certifications form the cornerstone of Titan Pharmaceutical’s global expansion. The company has obtained authoritative qualifications including EU-GMP and CEP certificates, and successfully passed official audits conducted by authorities from Germany and Austria. These credentials verify that Titan Pharmaceutical’s quality management system meets stringent European standards and enable market access to major global pharmaceutical markets.

Titan Pharmaceutical began its overseas market expansion back in 2003. After decades of development, its products have been exported to Europe, the Americas, Southeast Asia, South Asia, the Middle East and beyond. Titan has built stable long-term partnerships with many internationally renowned pharmaceutical companies and established a trusted brand reputation in the global API sector.

Looking Ahead: Hand in Hand for Win-Win Outcomes

While CPHI Milan has concluded, Titan Pharmaceutical’s journey in global market development continues. Moving forward, Titan Pharmaceutical will uphold its core philosophy of “Quality as Foundation, Integrity for Sustainable Business”. We will further expand our global layout and cooperate with more partners to supply high-quality cephalosporin APIs for the worldwide pharmaceutical supply chain, writing a new chapter of win-win collaboration together.